Wistron, through its subsidiary Wistron Medical Technology, has been advancing into the smart healthcare field with its self-developed non-contact AI medical device, BestShape VS. In collaboration with Taipei Medical University and Shuang-Ho Hospital, the device has undergone clinical validation in various specialties, including cardiology, pulmonology, and hemodialysis centers. The company anticipates obtaining Taiwan’s Class II smart medical device certification as early as next year for respiratory disease screening. This partnership has already enabled the integration of BestShape VS into Taipei Medical University’s healthcare system.
Jhun-Tung Huang, Chairman of Wistron Medical, emphasized that collaborating with Taipei Medical University and its affiliated hospitals facilitates the widespread adoption of Wistron Medical’s products in more healthcare facilities. He expressed hopes to further expand into the Southeast Asian medical market, bringing smart healthcare technologies closer to everyday life and offering precise and convenient medical services to more patients.
On November 20, Wistron Medical signed a memorandum of understanding (MOU) with Taipei Medical University, marking a new phase of collaboration. The partnership will focus on clinical validation research for smart medical devices, the development of patents, and the exploration of viable business models. Additionally, a joint talent cultivation program will integrate technology and medicine, deepening industry-academia cooperation and driving the development of more smart and precision medical solutions.
The non-contact AI smart care system has been a core product line for Wistron Medical. Leveraging millimeter-wave radar technology combined with AIoT, machine learning, and deep learning, the BestShape VS can continuously monitor and analyze vital signs such as respiration, heart rate, blood pressure, and sleep quality without interfering with patients' daily lives. This helps clinicians make accurate diagnoses and improves the efficiency of care.
In collaboration with Shuang-Ho Hospital, BestShape VS has been applied in several research projects, including negative-pressure isolation rooms in pulmonology. During the COVID-19 pandemic, it supported a “tiered zero-contact physiological monitoring and respiratory care platform” and has since been extended to assist in lung cancer diagnosis and treatment. In cardiology, the system has been employed to monitor heart failure, while in nephrology, it predicts hypotension in dialysis patients.
Since 2019, Wistron Medical has partnered with Wen-Te Liu, former director of Shuang-Ho Hospital’s Sleep Center and now Chairman of Ascension Medical Technology, on a series of sleep monitoring studies. Findings indicate that BestShape VS can detect obstructive sleep apnea (OSA) and periodic breathing (PB), aiding in the early prediction of potential cardiac conditions.
The unique features of BestShape VS, including its non-contact physiological monitoring, lightweight design, and ease of installation, position it as a valuable tool for continuous monitoring of inpatients. This allows early detection of conditions such as sleep apnea, heart disease, or respiratory disorders. By providing clinicians with continuous data analysis, the system supports proactive treatment strategies, helping physicians shift from reactive care to proactive management and improving patient outcomes.
Resource: 緯創旗下 緯醫AI醫材 攜北醫攻東南亞
